Interesting facts
Interesting Facts about (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
This complex organic compound represents an intriguing area of study in the field of medicinal chemistry and biochemistry. Here are some notable aspects:
- Stereochemistry: The various chiral centers in this compound play a crucial role in its biological activity. The balance of stereoisomers can significantly influence how this compound interacts with biological systems.
- Structure-Activity Relationship (SAR): Understanding the coupling between the molecular structure and its pharmacological activity opens avenues for drug design. By altering specific functional groups, scientists aim to enhance efficacy or reduce toxicity.
- Biological Applications: Compounds of this nature often exhibit properties that can be vital in pharmacology, such as anti-inflammatory or anticancer effects, making them valuable in therapeutic applications.
- Complexity: The multi-ring structure reflects the intricate nature of natural products, showcasing the beauty of organic synthesis and the challenges faced in isolating such compounds from natural sources.
- Research Potential: With ongoing studies exploring the pathways of metabolism and mechanisms of action, this compound is likely to attract significant attention within the pharmaceutical industry.
As a thought-provoking instance of organic chemistry, this compound encourages researchers to consider the subtle nuances of molecular interactions and the potential for innovative therapeutic solutions.
Synonyms
dehydrocholic acid
81-23-2
Decholin
Dehystolin
Dilabil
Ketocholanic acid
Felacrinos
Procholon
Sanocholen
Chologon
Oxycholin
Triketocholanic acid
Bilidren
Bilostat
Cholagon
Cholimed
Dehychol
Didrocolo
Drenobyl
Novocolin
Acolen
Dehycon
Didocol
Erebile
Hykolex
Deidrocolico Vita
Biochol
Dehycol
Ketochol
Khologon
dehydrocholate
Doxycholpotassium
Cholan DH
Cholic acid, dehydro-
Dee-Co
3,7,12-Trioxocholanic acid
3,7,12-Trioxo-5beta-cholanic acid
3,7,12-Triketocholanic acid
Acide dehydrocholique
3,7,12-Trioxo-5beta-cholan-24-oic acid
3,7,12-Triketo-5beta-cholanoic acid
Dehydrocholsaeure
Acido dehidrocolico
Hydrochol
NSC-8796
Decholin (TN)
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
DTXSID2022888
CHEBI:31459
Cholan-24-oic acid, 3,7,12-trioxo-, (5beta)-
Cholan-24-oic acid, 3,7,12-trioxo-, (5.beta.)-
(5beta)-3,7,12-trioxocholan-24-oic acid
MFCD00066410
NH5000009I
MLS000069501
MLS001076501
DTXCID402888
DEHYDROCHOLIC ACID [MI]
81-23-2 (acid)
DEHYDROCHOLIC ACID [INN]
DEHYDROCHOLIC ACID [JAN]
DEHYDROCHOLIC ACID [VANDF]
DEHYDROCHOLIC ACID [MART.]
DEHYDROCHOLIC ACID [USP-RS]
DEHYDROCHOLIC ACID [WHO-DD]
SMR000058603
DEHYDROCHOLIC ACID [USP MONOGRAPH]
3,7,12-Trioxo-5.beta.-cholan-24-oic acid
(R)-4-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Atrocholin
Cholepatin
DEHYDROCHOLIC ACID (MART.)
DEHYDROCHOLIC ACID (USP-RS)
Dehydrocholsaeure [German]
Acido deidrocolico
Acido deidrocolico [DCIT]
DEHYDROCHOLIC ACID (USP MONOGRAPH)
Acido dehidrocolico [Spanish]
Acide dehydrocholique [French]
Acidum dehydrocholicum [Latin]
Acidum dehydrocholicum
Acido dehidrocolico [INN-Spanish]
Acide dehydrocholique [INN-French]
Acidum dehydrocholicum [INN-Latin]
NSC 8796
EINECS 201-335-7
BRN 3226734
5beta-Cholanic acid, 3,7,12-trioxo-
Dilahil
DehydroCA
dehydocholic acid
3,7,12-Trioxo-5-beta-cholan-24-oic acid
UNII-NH5000009I
Dehydro-CA
dehydrocholate-acid
NCGC00095777-01
Cholan-24-oic acid, 3,7,12-trioxo-, (5b)-
Prestwick_498
5beta-Cholanic acid-3,5,12-trione
Cholan-24-oic acid, 3,7,12-trioxo-, (5-beta)-
Dehydrocholic acid [USP:INN:BAN:JAN]
(4R)-4-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-17-yl)pentanoate
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
Opera_ID_1391
Prestwick3_000123
3,12-Trioxocholanic acid
5beta-Cholan-24-oic acid, 3,7,12-trioxo-
3,12-Triketocholanic acid
5-beta-Cholan-24-oic acid, 3,7,12-trioxo-
SCHEMBL26391
BSPBio_000166
4-10-00-03478 (Beilstein Handbook Reference)
MLS001424181
Dehydrocholic acid (Standard)
BPBio1_000184
CHEMBL514446
HY-B1393R
NSC8796
HMS2052A11
HMS2095I08
HMS2235J07
HMS3712I08
HY-B1393
3,7,12-Trioxo-24-cholanic acid
Purified dehydrocholic acid (JP17)
Tox21_111519
LMST04010106
PDSP2_000076
s4562
3,12-Trioxo-5.beta.-cholanic acid
Dehydrocholic acid (JP17/USP/INN)
Dehydrocholic acid, >=99.0% (T)
3,12-Triketo-5.beta.-cholanic acid
AKOS024284359
Tox21_111519_1
3,12-Triketo-5.beta.-cholanoic acid
5.beta.-Cholanic acid,7,12-trioxo-
CCG-101103
CS-4902
DB11622
FD11044
NC00353
3,7,12-Trioxo-5.beta.-cholanic acid
3,7,12-Trioxocholan-24-oic acid #
3,7,12-Triketo-5.beta.-cholanic acid
NCGC00024025-03
NCGC00024025-05
3,7,12-Triketo-5.beta.-cholanoic acid
4-((1S,2S,7S,11S,10R,14R,15R)-2,15-dimethyl-5,9,16-trioxotetracyclo[8.7.0.0<2, 7>.0<11,15>]heptadec-14-yl)pentanoic acid
5.beta.-Cholanic acid, 3,7,12-trioxo-
3,12-Trioxo-5.beta.-cholan-24-oic acid
5.beta.-Cholan-24-oic acid,7,12-trioxo-
D0042
NS00004676
D01693
D94651
3,7,12-Tri-keto-5.beta.-Cholan-24-oic acid
5.beta.-Cholan-24-oic acid, 3,7,12-trioxo-
EN300-7402612
Cholan-24-oic acid,7,12-trioxo-, (5.beta.)-
Q903387
SR-01000003022
SR-01000003022-3
BRD-K90976994-001-02-1
3,7,12-Trioxo-5beta-cholanic acid 5beta-Cholanic acid-3,5,12-trione
Dehydrocholic acid, United States Pharmacopeia (USP) Reference Standard
(4R)-4-[(1R,3aS,3bR,5aS,9aS,9bS,11aR)-9a,11a-dimethyl-4,7,11-trioxo-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(R)-4-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoicacid
201-335-7
Solubility of (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
The solubility of the compound (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid can present interesting challenges due to its complex structure. The solubility behavior of compounds like this one can depend on several influencing factors:
In summary, the solubility of this compound is likely to be quite specific to the solvent system utilized, influenced by a balance between its polar and non-polar characteristics. As a result, this compound may show varying solubility profiles, being more soluble in some environments than others.